UNI-EN 224:Notification for buy-back shares
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 224 | / | 2023 | |||||||
| Date of issue: | 2023-12-12 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification for buy-back shares | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, December 12, 2023 - Pursuant to the requirements of Art. 100t of the Law on Public Offering of Securities, "Sopharma" AD (SFA: BSE AD, SPH: Warsaw Stock Exchange) announces that on the basis of Art. 187b of the Commercial Law and Art. 111, para. 5 and para. 6 of the Law on Public Offering of Securities and in connection with the decision of the General Meeting of Shareholders of the company, held on 4 August 2023, and the decision of the Board of Directors of the company from 12 December 2023, "Sopharma" AD notifies that the company intends to buy back treasury shares within the limit according to Art. 111, para. 5 of the Law on Public Offering of Securities, as follows: - Number of shares subject to redemption – 184,000 (оne hundred and eighty-four thousand) shares; - Buy-back price – BGN 6.10 for one share of the company's capital; - Purchase date: 13 December 2023; - Licensed investment intermediary to whom the purchase order was given – “First Financial Brokerage House” AD | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_Buy-back_13122023_EN_espi.pdf SFA_Buy-back_13122023_EN_espi.pdf | Notification for buy-back shares | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-12-12 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 13.95 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
